Immunohistochemical study of cyclooxygenase-2 in skin tumors

References

• Groot DJ, Vries EG, Groen HJ, Jong S. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol. 2007;61:52–69.
   PubMed Web of Science ®Google Scholar
• Kagoura M, Toyoda M, Matsui C, Morohashi M. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol. 2001;28:298–302.
   PubMed Web of Science ®Google Scholar
• Nijsten T, Colpaert CG, Vermeulen PB, Harris AL, Van Marck E, Lambert J. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Br J Dermatol. 2004;151:837–845.
   PubMed Web of Science ®Google Scholar
• Kim KH, Park EJ, Seo YJ, Cho HS, Kim CW, Kim KJ, et al. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol. 2006;33:319–312.
   PubMed Web of Science ®Google Scholar
• Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA. 2002;99:12483–12488.
   PubMed Web of Science ®Google Scholar
• Meric JB, Rottey S, Olaussen K, Soria JC, Khayat D, Rixe O, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol. 2006;59:51–64.
   PubMed Web of Science ®Google Scholar
• Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 2004;18:300–310.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–266.
   PubMed Web of Science ®Google Scholar
• Fischer SM, Conti CJ, Viner J, Aldaz CM, Lubet RA. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis. 2003;24:945–952.
   PubMed Web of Science ®Google Scholar
• Airton G, Lorivaldo M. Risk factors for basal cell carcinoma in a southern Brazilian population: a case–control study. Int J Dermatol. 2011;50:1286–1290.
   PubMed Web of Science ®Google Scholar
• Khodaeiani E, Amirnia M, Babaei-Nazhad S, Esmaeili H, Razzagh-Karimi E, Alikhah H. Clinicopathologic study of basal cell carcinoma. Res J Biol Sci. 2010;5:293–296.
   Google Scholar
• Babaye-Nazhad S, Amirnia M, Alikhah H, Khodaeyani E, Atapour N. Safety margin in excision of basal cell carcinoma. Pak J Biol Sci. 2009;12:1408–1414.
   PubMedGoogle Scholar
• Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006;155:9–22.
   PubMed Web of Science ®Google Scholar
• Schwartz RA. Chapter 5. Squamous cell carcinoma. Skin Cancer: Recognition and Management. 2nd ed. Blackwell Publishing, 2008.
   Google Scholar
• Schwartz RA. Chapter 4. Bowen's disease. Skin Cancer: Recognition and Management. 2nd ed. Blackwell Publishing, 2008.
   Google Scholar
• Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer. 2001;84:1188–1192.
   PubMed Web of Science ®Google Scholar
• Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer. 2000;82:1364–1369.
   PubMed Web of Science ®Google Scholar
• Irani J, Ravery V, Pariente JL, Chartier-Kastler E, Lechevallier E, Soulie M, et al. Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol. 2002;168:1985–1988.
   PubMed Web of Science ®Google Scholar
• Muscat JE, Chen SQ, Richie JP Jr, Altorki NK, Citron M, Olson S, et al. Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer. 2003;97:1732–1736.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 2002;99:13926–13931.
   PubMed Web of Science ®Google Scholar
• Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem. 2001;276:18563–18569.
   PubMed Web of Science ®Google Scholar
• Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, et al. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res. 1997;57:1625–1629.
   PubMed Web of Science ®Google Scholar
• Karuppu D, Kalus A, Simpson ER, Clyne C. Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development. Breast Cancer Res Treat. 2002;76:103–109.
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997;94:3336–3340.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kanekura T, Kanzaki T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer. 2000;86:667–671.
   PubMed Web of Science ®Google Scholar
• Huang C, Ma WY, Hanenberger D, Cleary MP, Bowden GT, Dong Z. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem. 1997;42:325–331.
   Google Scholar
• Müller-Decker K, Reinerth G, Krieg P, Zimmermann R, Heise H, Bayerl C, Marks F, Fürstenberger G. Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer. 1999;82:648–656.
   PubMed Web of Science ®Google Scholar
• Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:35–57.
   PubMed Web of Science ®Google Scholar
• Siegle I, Klein T, Backman JT, Saal JG, Nüsing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 1998;41:122–129.
   PubMed Web of Science ®Google Scholar
• Kandil HM, Tanner G, Smalley W, Halter S, Radhika A, Dubois RN. Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci. 2001;46:785–789.
   PubMed Web of Science ®Google Scholar
• Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci. 2000;30:3–21.
   PubMed Web of Science ®Google Scholar
• Dannenberg AJ, Altorki NK, Boyle JO, Lin DT, Subbaramaiah K. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann NY Acad Sci. 2001;952:109–115.
   PubMed Web of Science ®Google Scholar
• Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 2000;105:1589–1594.
   PubMed Web of Science ®Google Scholar
• Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3:53–61.
   PubMed Web of Science ®Google Scholar
• Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis. 1999;20:1939–1944.
   PubMed Web of Science ®Google Scholar
• Luo M, Lee S, Brock TG. Leukotriene synthesis by epithelial cells. Histol Histopathol. 2003;18:587–595.
   PubMed Web of Science ®Google Scholar
• Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000;60:6846–6850.
   PubMed Web of Science ®Google Scholar
• Gallo O, Fabbroni V, Sardi I, Magnelli L, Boddi V, Franchi A. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas. Biochem Biophys Res Commun. 2002;299:517–524.
   PubMed Web of Science ®Google Scholar
• Moyisch KB, Menezes RJ, Ronani A, Swede H, Reid ME, Cummings KM, et al. Regular aspirin use and lung cancer risk. BMC Cancer. 2002;2:31–38.
   PubMed Web of Science ®Google Scholar
• Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891–899.
   PubMed Web of Science ®Google Scholar